(December 18, 2020) Today, front line healthcare workers at Nemours duPont Hospital for Children began rolling up their sleeves to receive the first round of the COVID-19 vaccine in Delaware. A process was created at Nemours to identify and prioritize associates who are critical to patient care. While the vaccine is not mandatory, all Nemours associates are highly encouraged to get it.
Nemours has received 750 doses for this first round of vaccinations. The vaccines are being administered in a location that observes social distancing and safety protocols.
Vickie Freeman, a registered nurse at Nemours duPont Hospital for Children was the first to receive the vaccine. “I feel like I’m a pioneer. I did not get a chance to be in the military so I feel like I am a soldier and I’m fighting this virus.”
About Nemours Children’s Health System
Nemours is an internationally recognized children's health system that owns and operates the two free-standing children’s hospitals: the Nemours/Alfred I. duPont Hospital for Children in Wilmington, Del., and Nemours Children's Hospital in Orlando, Fla., along with outpatient facilities in five states, delivering pediatric primary, specialty and urgent care. Nemours also powers the world’s most-visited website for information on the health of children and teens, KidsHealth.org, and offers on-demand, online video patient visits through Nemours CareConnect. Nemours ReadingBrightstart.org is a program dedicated to preventing reading failure in young children, grounded in Nemours’ understanding that child health and learning are inextricably linked, and that reading level is a strong predictor of adult health.
Established as The Nemours Foundation through the legacy and philanthropy of Alfred I. duPont, Nemours provides pediatric clinical care, research, education, advocacy and prevention programs to families in the communities it serves
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.